Our analysis also indicated that the downregulation of NDUFB2 occurs in blood samples of IBD patients, linking this alteration to key mechanisms such as mitochondrial dysfunction, impaired oxidative phosphorylation, and excessive ROS production, ultimately contributing to blood inflammation. The gene discussed is NDUFB2; the disease is inflammatory bowel disease.